{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.03, "width": 1700, "height": 2236, "unit": "pixel", "lines": [{"boundingBox": [1110, 286, 1273, 287, 1272, 315, 1109, 314], "text": "8 January 2003", "words": [{"boundingBox": [1111, 288, 1126, 288, 1127, 313, 1112, 313], "text": "8"}, {"boundingBox": [1131, 288, 1216, 289, 1215, 315, 1132, 313], "text": "January"}, {"boundingBox": [1221, 288, 1273, 287, 1273, 315, 1220, 315], "text": "2003"}]}, {"boundingBox": [338, 325, 589, 328, 588, 356, 337, 354], "text": "To: MPDRAP I Leader", "words": [{"boundingBox": [341, 328, 375, 328, 378, 354, 344, 354], "text": "To:"}, {"boundingBox": [381, 328, 490, 329, 491, 356, 383, 354], "text": "MPDRAP"}, {"boundingBox": [495, 329, 505, 329, 507, 356, 496, 356], "text": "I"}, {"boundingBox": [511, 329, 587, 328, 588, 356, 512, 356], "text": "Leader"}]}, {"boundingBox": [341, 366, 950, 368, 950, 398, 340, 396], "text": "cc: CEOs and General Managers of Pharmaceutical Units", "words": [{"boundingBox": [341, 368, 372, 368, 373, 396, 342, 396], "text": "cc:"}, {"boundingBox": [378, 368, 441, 368, 442, 396, 378, 396], "text": "CEOs"}, {"boundingBox": [446, 368, 488, 368, 489, 396, 447, 396], "text": "and"}, {"boundingBox": [493, 368, 574, 368, 575, 396, 494, 396], "text": "General"}, {"boundingBox": [580, 368, 686, 368, 687, 397, 581, 396], "text": "Managers"}, {"boundingBox": [692, 368, 714, 368, 714, 397, 693, 397], "text": "of"}, {"boundingBox": [719, 368, 883, 369, 884, 398, 720, 397], "text": "Pharmaceutical"}, {"boundingBox": [889, 369, 948, 369, 949, 398, 889, 398], "text": "Units"}]}, {"boundingBox": [423, 446, 1188, 443, 1189, 475, 424, 477], "text": "My Concerns about sNDA for Actos 45mg in the USA (Reconfirmation)", "words": [{"boundingBox": [424, 447, 462, 447, 463, 477, 425, 477], "text": "My"}, {"boundingBox": [468, 447, 568, 446, 569, 477, 469, 477], "text": "Concerns"}, {"boundingBox": [574, 446, 634, 446, 635, 477, 575, 477], "text": "about"}, {"boundingBox": [640, 446, 704, 446, 705, 477, 641, 477], "text": "sNDA"}, {"boundingBox": [710, 446, 742, 446, 742, 477, 711, 477], "text": "for"}, {"boundingBox": [748, 446, 810, 446, 810, 476, 748, 477], "text": "Actos"}, {"boundingBox": [816, 446, 874, 446, 874, 476, 816, 476], "text": "45mg"}, {"boundingBox": [880, 446, 902, 446, 902, 476, 880, 476], "text": "in"}, {"boundingBox": [908, 446, 942, 446, 942, 475, 908, 476], "text": "the"}, {"boundingBox": [948, 446, 998, 446, 998, 475, 948, 475], "text": "USA"}, {"boundingBox": [1004, 446, 1188, 446, 1188, 473, 1004, 475], "text": "(Reconfirmation)"}]}, {"boundingBox": [867, 524, 1278, 524, 1278, 552, 868, 553], "text": "Pharmaceutical International Division", "words": [{"boundingBox": [872, 525, 1035, 528, 1035, 553, 872, 552], "text": "Pharmaceutical"}, {"boundingBox": [1040, 528, 1174, 527, 1175, 553, 1041, 553], "text": "International"}, {"boundingBox": [1180, 527, 1276, 524, 1276, 552, 1180, 553], "text": "Division"}]}, {"boundingBox": [1185, 566, 1276, 563, 1276, 590, 1186, 594], "text": "Y. Narai", "words": [{"boundingBox": [1187, 568, 1207, 566, 1208, 592, 1188, 592], "text": "Y."}, {"boundingBox": [1211, 566, 1276, 563, 1276, 591, 1212, 592], "text": "Narai"}]}, {"boundingBox": [337, 642, 1277, 643, 1276, 675, 336, 674], "text": "I express my opinion about the conclusion drawn at MPDRAP Committee Meeting", "words": [{"boundingBox": [340, 643, 354, 643, 354, 675, 339, 675], "text": "I"}, {"boundingBox": [360, 643, 443, 643, 443, 674, 360, 675], "text": "express"}, {"boundingBox": [450, 643, 491, 643, 491, 673, 449, 674], "text": "my"}, {"boundingBox": [497, 643, 582, 643, 582, 672, 497, 673], "text": "opinion"}, {"boundingBox": [589, 643, 653, 643, 653, 672, 588, 672], "text": "about"}, {"boundingBox": [659, 643, 697, 643, 696, 672, 659, 672], "text": "the"}, {"boundingBox": [703, 643, 823, 643, 823, 672, 702, 672], "text": "conclusion"}, {"boundingBox": [832, 643, 900, 643, 900, 672, 831, 672], "text": "drawn"}, {"boundingBox": [906, 643, 929, 643, 929, 672, 906, 672], "text": "at"}, {"boundingBox": [935, 643, 1050, 643, 1049, 673, 935, 672], "text": "MPDRAP"}, {"boundingBox": [1056, 643, 1176, 643, 1176, 674, 1055, 673], "text": "Committee"}, {"boundingBox": [1183, 643, 1276, 643, 1275, 675, 1182, 674], "text": "Meeting"}]}, {"boundingBox": [340, 682, 1275, 681, 1275, 712, 341, 713], "text": "where it was agreed that sNDA to obtain the approval of the 45mg combination", "words": [{"boundingBox": [341, 683, 412, 683, 411, 712, 341, 712], "text": "where"}, {"boundingBox": [417, 683, 442, 683, 442, 712, 417, 712], "text": "it"}, {"boundingBox": [448, 683, 496, 683, 495, 712, 447, 712], "text": "was"}, {"boundingBox": [501, 683, 579, 683, 579, 712, 501, 712], "text": "agreed"}, {"boundingBox": [585, 683, 633, 682, 632, 712, 584, 712], "text": "that"}, {"boundingBox": [638, 682, 709, 682, 708, 713, 638, 712], "text": "sNDA"}, {"boundingBox": [718, 682, 747, 682, 746, 713, 717, 713], "text": "to"}, {"boundingBox": [754, 682, 825, 682, 824, 713, 754, 713], "text": "obtain", "confidence": "Low"}, {"boundingBox": [832, 682, 872, 682, 872, 713, 832, 713], "text": "the"}, {"boundingBox": [880, 682, 979, 682, 978, 713, 879, 713], "text": "approval"}, {"boundingBox": [985, 682, 1015, 682, 1014, 713, 984, 713], "text": "of"}, {"boundingBox": [1021, 682, 1061, 682, 1060, 713, 1020, 713], "text": "the"}, {"boundingBox": [1069, 682, 1135, 682, 1134, 713, 1068, 713], "text": "45mg"}, {"boundingBox": [1141, 682, 1274, 682, 1273, 713, 1140, 713], "text": "combination"}]}, {"boundingBox": [338, 723, 1272, 724, 1271, 752, 337, 751], "text": "indications would be submitted, as well as the safety update based on the commitment", "words": [{"boundingBox": [341, 724, 460, 725, 459, 751, 340, 750], "text": "indications"}, {"boundingBox": [465, 725, 533, 725, 532, 752, 464, 751], "text": "would"}, {"boundingBox": [538, 725, 569, 725, 568, 752, 537, 752], "text": "be"}, {"boundingBox": [574, 725, 687, 725, 687, 753, 573, 752], "text": "submitted,"}, {"boundingBox": [693, 725, 716, 725, 716, 753, 692, 753], "text": "as"}, {"boundingBox": [721, 725, 771, 725, 770, 753, 721, 753], "text": "well"}, {"boundingBox": [776, 725, 800, 725, 799, 753, 775, 753], "text": "as"}, {"boundingBox": [805, 725, 840, 725, 840, 753, 804, 753], "text": "the"}, {"boundingBox": [846, 725, 912, 725, 911, 753, 845, 753], "text": "safety"}, {"boundingBox": [917, 725, 992, 725, 991, 753, 916, 753], "text": "update"}, {"boundingBox": [997, 725, 1060, 725, 1059, 752, 996, 753], "text": "based"}, {"boundingBox": [1065, 725, 1094, 725, 1093, 752, 1064, 752], "text": "on"}, {"boundingBox": [1100, 725, 1136, 725, 1135, 752, 1100, 752], "text": "the"}, {"boundingBox": [1141, 725, 1272, 724, 1271, 750, 1140, 752], "text": "commitment"}]}, {"boundingBox": [337, 759, 429, 761, 428, 789, 336, 788], "text": "studies.", "words": [{"boundingBox": [341, 760, 429, 761, 428, 789, 342, 789], "text": "studies."}]}, {"boundingBox": [341, 802, 1282, 802, 1281, 831, 340, 830], "text": "As you know, Actos is the essential product for IPNA and is vital to the survival of", "words": [{"boundingBox": [343, 803, 373, 803, 374, 831, 344, 831], "text": "As"}, {"boundingBox": [379, 803, 422, 804, 423, 831, 380, 831], "text": "you"}, {"boundingBox": [428, 804, 497, 804, 498, 831, 429, 831], "text": "know,"}, {"boundingBox": [503, 804, 567, 805, 568, 832, 504, 831], "text": "Actos"}, {"boundingBox": [572, 805, 595, 805, 596, 832, 573, 832], "text": "is"}, {"boundingBox": [600, 805, 636, 806, 637, 832, 601, 832], "text": "the"}, {"boundingBox": [642, 806, 736, 806, 737, 832, 643, 832], "text": "essential"}, {"boundingBox": [741, 806, 828, 806, 828, 832, 742, 832], "text": "product"}, {"boundingBox": [833, 806, 871, 806, 872, 832, 834, 832], "text": "for"}, {"boundingBox": [876, 806, 944, 806, 945, 832, 877, 832], "text": "IPNA", "confidence": "Low"}, {"boundingBox": [951, 806, 993, 806, 994, 831, 952, 832], "text": "and"}, {"boundingBox": [998, 806, 1021, 806, 1022, 831, 999, 831], "text": "is"}, {"boundingBox": [1026, 806, 1075, 805, 1076, 831, 1027, 831], "text": "vital"}, {"boundingBox": [1081, 805, 1107, 805, 1108, 831, 1082, 831], "text": "to"}, {"boundingBox": [1113, 805, 1148, 805, 1149, 831, 1114, 831], "text": "the"}, {"boundingBox": [1154, 805, 1242, 803, 1243, 831, 1155, 831], "text": "survival"}, {"boundingBox": [1248, 803, 1280, 803, 1281, 831, 1249, 831], "text": "of"}]}, {"boundingBox": [337, 837, 1276, 840, 1275, 871, 336, 869], "text": "TPNA. If unfavorable revisions in the Actos labeling are made, it invites the serious risk", "words": [{"boundingBox": [342, 839, 417, 840, 418, 868, 344, 868], "text": "TPNA."}, {"boundingBox": [422, 840, 441, 840, 443, 868, 423, 868], "text": "If"}, {"boundingBox": [447, 840, 571, 842, 572, 869, 448, 868], "text": "unfavorable"}, {"boundingBox": [577, 842, 674, 843, 675, 870, 578, 869], "text": "revisions"}, {"boundingBox": [679, 843, 700, 843, 701, 870, 680, 870], "text": "in"}, {"boundingBox": [706, 843, 740, 843, 741, 870, 707, 870], "text": "the"}, {"boundingBox": [746, 843, 807, 843, 808, 870, 747, 870], "text": "Actos"}, {"boundingBox": [813, 843, 900, 843, 901, 871, 813, 870], "text": "labeling"}, {"boundingBox": [906, 843, 937, 843, 937, 871, 907, 871], "text": "are"}, {"boundingBox": [942, 843, 1007, 843, 1008, 871, 943, 871], "text": "made,"}, {"boundingBox": [1013, 843, 1030, 843, 1030, 871, 1013, 871], "text": "it"}, {"boundingBox": [1036, 843, 1106, 842, 1106, 870, 1036, 871], "text": "invites"}, {"boundingBox": [1112, 842, 1146, 842, 1146, 870, 1112, 870], "text": "the"}, {"boundingBox": [1152, 842, 1226, 841, 1226, 870, 1152, 870], "text": "serious"}, {"boundingBox": [1232, 841, 1276, 840, 1276, 870, 1232, 870], "text": "risk"}]}, {"boundingBox": [342, 878, 1278, 879, 1277, 910, 341, 909], "text": "to Actos in the US. TPNA is now under attack from GSK, especially by Avandamet and", "words": [{"boundingBox": [342, 879, 365, 879, 365, 909, 342, 909], "text": "to", "confidence": "Low"}, {"boundingBox": [370, 879, 430, 879, 430, 909, 371, 909], "text": "Actos"}, {"boundingBox": [436, 879, 457, 879, 457, 909, 436, 909], "text": "in"}, {"boundingBox": [462, 879, 497, 879, 497, 909, 463, 909], "text": "the"}, {"boundingBox": [503, 879, 547, 879, 547, 909, 503, 909], "text": "US."}, {"boundingBox": [553, 879, 618, 879, 618, 909, 552, 909], "text": "TPNA"}, {"boundingBox": [624, 879, 643, 879, 642, 909, 623, 909], "text": "is"}, {"boundingBox": [649, 879, 695, 879, 694, 910, 648, 910], "text": "now"}, {"boundingBox": [702, 879, 764, 879, 763, 910, 702, 910], "text": "under"}, {"boundingBox": [769, 879, 833, 879, 832, 910, 769, 910], "text": "attack"}, {"boundingBox": [838, 879, 888, 879, 887, 910, 838, 910], "text": "from"}, {"boundingBox": [898, 879, 957, 879, 956, 910, 897, 910], "text": "GSK,"}, {"boundingBox": [963, 879, 1067, 879, 1066, 910, 962, 910], "text": "especially"}, {"boundingBox": [1072, 879, 1103, 879, 1102, 910, 1071, 910], "text": "by"}, {"boundingBox": [1109, 879, 1230, 879, 1228, 910, 1108, 910], "text": "Avandamet"}, {"boundingBox": [1236, 879, 1278, 879, 1276, 910, 1234, 910], "text": "and"}]}, {"boundingBox": [339, 919, 1279, 918, 1279, 948, 340, 949], "text": "is eager to maintain their market share. In addition to this attack, if the indications of", "words": [{"boundingBox": [342, 921, 362, 921, 361, 947, 340, 947], "text": "is"}, {"boundingBox": [368, 921, 430, 921, 428, 948, 366, 947], "text": "eager"}, {"boundingBox": [435, 921, 459, 921, 457, 948, 433, 948], "text": "to"}, {"boundingBox": [464, 921, 559, 921, 557, 949, 462, 948], "text": "maintain"}, {"boundingBox": [565, 921, 617, 921, 616, 949, 564, 949], "text": "their"}, {"boundingBox": [622, 921, 700, 921, 698, 949, 621, 949], "text": "market"}, {"boundingBox": [705, 921, 770, 920, 769, 950, 703, 949], "text": "share."}, {"boundingBox": [775, 920, 801, 920, 800, 950, 774, 950], "text": "In"}, {"boundingBox": [806, 920, 898, 920, 896, 950, 805, 950], "text": "addition"}, {"boundingBox": [903, 920, 929, 920, 927, 950, 902, 950], "text": "to"}, {"boundingBox": [934, 920, 975, 920, 974, 950, 933, 950], "text": "this"}, {"boundingBox": [980, 920, 1052, 919, 1051, 949, 979, 950], "text": "attack,"}, {"boundingBox": [1058, 919, 1078, 919, 1077, 949, 1057, 949], "text": "if"}, {"boundingBox": [1083, 919, 1120, 919, 1119, 949, 1082, 949], "text": "the"}, {"boundingBox": [1125, 919, 1245, 918, 1244, 948, 1124, 949], "text": "indications"}, {"boundingBox": [1250, 918, 1278, 918, 1277, 948, 1249, 948], "text": "of"}]}, {"boundingBox": [344, 958, 1269, 959, 1268, 988, 343, 987], "text": "Actos are reduced, TPNA is pushed into critical situation. This issue seriously damages", "words": [{"boundingBox": [344, 959, 404, 959, 404, 988, 344, 988], "text": "Actos"}, {"boundingBox": [410, 959, 444, 959, 444, 988, 410, 988], "text": "are"}, {"boundingBox": [449, 959, 544, 959, 544, 987, 450, 988], "text": "reduced,", "confidence": "Low"}, {"boundingBox": [549, 959, 615, 959, 615, 987, 549, 987], "text": "TPNA"}, {"boundingBox": [621, 959, 640, 959, 640, 987, 621, 987], "text": "is"}, {"boundingBox": [646, 959, 723, 959, 722, 987, 645, 987], "text": "pushed"}, {"boundingBox": [729, 959, 772, 959, 771, 987, 728, 987], "text": "into"}, {"boundingBox": [778, 959, 853, 960, 852, 987, 777, 987], "text": "critical"}, {"boundingBox": [859, 960, 961, 960, 960, 988, 858, 987], "text": "situation."}, {"boundingBox": [966, 960, 1011, 960, 1010, 988, 965, 988], "text": "This"}, {"boundingBox": [1017, 960, 1072, 960, 1071, 988, 1016, 988], "text": "issue"}, {"boundingBox": [1078, 960, 1177, 960, 1176, 988, 1076, 988], "text": "seriously"}, {"boundingBox": [1183, 960, 1268, 960, 1266, 989, 1182, 988], "text": "damages"}]}, {"boundingBox": [333, 995, 1278, 995, 1278, 1027, 334, 1027], "text": "not only US market but also Takeda's global strategy. Therefore, HQ should be", "words": [{"boundingBox": [338, 997, 384, 998, 384, 1028, 338, 1028], "text": "not"}, {"boundingBox": [390, 998, 442, 998, 442, 1028, 390, 1028], "text": "only"}, {"boundingBox": [452, 998, 490, 998, 490, 1028, 452, 1028], "text": "US"}, {"boundingBox": [498, 998, 581, 999, 581, 1028, 498, 1028], "text": "market"}, {"boundingBox": [587, 999, 631, 999, 631, 1028, 587, 1028], "text": "but"}, {"boundingBox": [637, 999, 685, 999, 685, 1028, 637, 1028], "text": "also"}, {"boundingBox": [695, 999, 793, 999, 793, 1028, 695, 1028], "text": "Takeda's"}, {"boundingBox": [799, 999, 875, 999, 875, 1028, 799, 1028], "text": "global"}, {"boundingBox": [881, 999, 979, 998, 978, 1028, 881, 1028], "text": "strategy."}, {"boundingBox": [985, 998, 1102, 997, 1102, 1028, 984, 1028], "text": "Therefore,"}, {"boundingBox": [1108, 997, 1150, 997, 1150, 1028, 1108, 1028], "text": "HQ"}, {"boundingBox": [1162, 997, 1240, 996, 1240, 1027, 1162, 1028], "text": "should"}, {"boundingBox": [1246, 996, 1278, 995, 1277, 1027, 1245, 1027], "text": "be"}]}, {"boundingBox": [336, 1040, 897, 1039, 897, 1068, 337, 1068], "text": "extremely cautious about the issues related to Actos.", "words": [{"boundingBox": [340, 1040, 446, 1041, 447, 1068, 340, 1068], "text": "extremely"}, {"boundingBox": [452, 1041, 542, 1041, 542, 1068, 452, 1068], "text": "cautious"}, {"boundingBox": [547, 1041, 605, 1041, 606, 1068, 548, 1068], "text": "about"}, {"boundingBox": [611, 1041, 644, 1041, 645, 1068, 612, 1068], "text": "the"}, {"boundingBox": [649, 1041, 713, 1041, 714, 1068, 650, 1068], "text": "issues"}, {"boundingBox": [719, 1041, 792, 1040, 793, 1068, 720, 1068], "text": "related"}, {"boundingBox": [797, 1040, 821, 1040, 822, 1068, 799, 1068], "text": "to"}, {"boundingBox": [827, 1040, 896, 1040, 898, 1069, 828, 1068], "text": "Actos."}]}, {"boundingBox": [341, 1072, 1272, 1075, 1272, 1108, 340, 1105], "text": "If this sNDA raises the argument for the indications of Actos, for example, reductions in", "words": [{"boundingBox": [341, 1075, 356, 1075, 357, 1105, 342, 1104], "text": "If"}, {"boundingBox": [362, 1075, 403, 1075, 404, 1105, 363, 1105], "text": "this"}, {"boundingBox": [409, 1075, 473, 1075, 474, 1105, 410, 1105], "text": "sNDA"}, {"boundingBox": [479, 1075, 542, 1076, 542, 1105, 480, 1105], "text": "raises"}, {"boundingBox": [547, 1076, 581, 1076, 581, 1105, 548, 1105], "text": "the"}, {"boundingBox": [586, 1076, 686, 1076, 686, 1105, 587, 1105], "text": "argument"}, {"boundingBox": [692, 1076, 725, 1076, 725, 1106, 692, 1105], "text": "for"}, {"boundingBox": [731, 1076, 762, 1076, 762, 1106, 731, 1106], "text": "the"}, {"boundingBox": [768, 1076, 885, 1076, 885, 1106, 768, 1106], "text": "indications"}, {"boundingBox": [891, 1076, 916, 1076, 916, 1106, 891, 1106], "text": "of"}, {"boundingBox": [922, 1076, 988, 1076, 988, 1107, 922, 1106], "text": "Actos,"}, {"boundingBox": [994, 1076, 1027, 1076, 1027, 1107, 994, 1107], "text": "for"}, {"boundingBox": [1033, 1076, 1128, 1076, 1129, 1107, 1033, 1107], "text": "example,"}, {"boundingBox": [1134, 1076, 1243, 1075, 1243, 1108, 1134, 1107], "text": "reductions"}, {"boundingBox": [1249, 1075, 1271, 1075, 1271, 1108, 1249, 1108], "text": "in"}]}, {"boundingBox": [334, 1113, 1275, 1113, 1275, 1145, 335, 1146], "text": "the indications, the issues will come to a critical path like as I mentioned. So we should", "words": [{"boundingBox": [340, 1116, 373, 1117, 374, 1144, 341, 1144], "text": "the"}, {"boundingBox": [379, 1117, 503, 1118, 504, 1145, 380, 1144], "text": "indications,"}, {"boundingBox": [509, 1118, 542, 1118, 542, 1145, 509, 1145], "text": "the"}, {"boundingBox": [547, 1118, 613, 1118, 614, 1146, 548, 1145], "text": "issues"}, {"boundingBox": [619, 1118, 661, 1118, 661, 1146, 619, 1146], "text": "will"}, {"boundingBox": [666, 1118, 727, 1119, 727, 1146, 667, 1146], "text": "come"}, {"boundingBox": [732, 1119, 754, 1119, 755, 1146, 733, 1146], "text": "to"}, {"boundingBox": [760, 1119, 774, 1118, 775, 1146, 760, 1146], "text": "a"}, {"boundingBox": [780, 1118, 853, 1118, 853, 1146, 780, 1146], "text": "critical"}, {"boundingBox": [859, 1118, 904, 1118, 905, 1146, 859, 1146], "text": "path"}, {"boundingBox": [910, 1118, 954, 1118, 954, 1146, 910, 1146], "text": "like"}, {"boundingBox": [959, 1118, 981, 1117, 981, 1146, 959, 1146], "text": "as"}, {"boundingBox": [987, 1117, 998, 1117, 998, 1146, 987, 1146], "text": "I"}, {"boundingBox": [1003, 1117, 1124, 1116, 1124, 1146, 1003, 1146], "text": "mentioned."}, {"boundingBox": [1130, 1116, 1159, 1115, 1159, 1146, 1130, 1146], "text": "So"}, {"boundingBox": [1164, 1115, 1197, 1115, 1197, 1146, 1164, 1146], "text": "we"}, {"boundingBox": [1203, 1115, 1274, 1113, 1274, 1146, 1203, 1146], "text": "should"}]}, {"boundingBox": [339, 1154, 1277, 1151, 1278, 1185, 340, 1187], "text": "go into action on condition that there is no such risk. Combination therapy in the US", "words": [{"boundingBox": [342, 1158, 370, 1158, 370, 1185, 342, 1185], "text": "go"}, {"boundingBox": [376, 1158, 422, 1158, 422, 1185, 376, 1185], "text": "into"}, {"boundingBox": [427, 1159, 495, 1159, 495, 1185, 427, 1185], "text": "action"}, {"boundingBox": [500, 1159, 530, 1159, 530, 1185, 500, 1185], "text": "on"}, {"boundingBox": [536, 1159, 639, 1160, 639, 1185, 536, 1185], "text": "condition"}, {"boundingBox": [644, 1160, 688, 1159, 689, 1185, 644, 1185], "text": "that"}, {"boundingBox": [694, 1159, 749, 1159, 749, 1185, 694, 1185], "text": "there"}, {"boundingBox": [754, 1159, 776, 1159, 776, 1185, 755, 1185], "text": "is"}, {"boundingBox": [781, 1159, 813, 1159, 813, 1185, 781, 1185], "text": "no"}, {"boundingBox": [818, 1159, 870, 1159, 870, 1185, 819, 1185], "text": "such"}, {"boundingBox": [875, 1159, 928, 1158, 929, 1185, 876, 1185], "text": "risk.", "confidence": "Low"}, {"boundingBox": [934, 1158, 1072, 1156, 1073, 1186, 935, 1185], "text": "Combination"}, {"boundingBox": [1078, 1156, 1161, 1155, 1162, 1186, 1079, 1186], "text": "therapy"}, {"boundingBox": [1167, 1155, 1192, 1154, 1193, 1186, 1168, 1186], "text": "in"}, {"boundingBox": [1197, 1154, 1234, 1153, 1235, 1186, 1198, 1186], "text": "the"}, {"boundingBox": [1240, 1153, 1275, 1152, 1276, 1186, 1241, 1186], "text": "US"}]}, {"boundingBox": [335, 1193, 1274, 1193, 1274, 1224, 336, 1225], "text": "market accounts for 64% of total Actos sales. (29% in combination with SU, 27%", "words": [{"boundingBox": [340, 1196, 419, 1196, 419, 1224, 340, 1224], "text": "market"}, {"boundingBox": [425, 1196, 523, 1196, 523, 1224, 425, 1224], "text": "accounts"}, {"boundingBox": [528, 1196, 566, 1196, 566, 1224, 528, 1224], "text": "for"}, {"boundingBox": [572, 1196, 626, 1196, 626, 1224, 572, 1224], "text": "64%"}, {"boundingBox": [632, 1196, 661, 1196, 660, 1224, 631, 1224], "text": "of"}, {"boundingBox": [666, 1196, 721, 1196, 720, 1224, 666, 1224], "text": "total"}, {"boundingBox": [726, 1196, 793, 1196, 793, 1224, 726, 1224], "text": "Actos"}, {"boundingBox": [799, 1196, 864, 1196, 864, 1224, 798, 1224], "text": "sales."}, {"boundingBox": [870, 1196, 931, 1195, 931, 1224, 869, 1224], "text": "(29%"}, {"boundingBox": [937, 1195, 962, 1195, 961, 1224, 936, 1224], "text": "in"}, {"boundingBox": [969, 1195, 1106, 1194, 1105, 1225, 969, 1224], "text": "combination"}, {"boundingBox": [1115, 1194, 1166, 1194, 1164, 1225, 1114, 1225], "text": "with"}, {"boundingBox": [1173, 1194, 1220, 1193, 1219, 1226, 1172, 1225], "text": "SU,"}, {"boundingBox": [1225, 1193, 1274, 1193, 1273, 1226, 1224, 1226], "text": "27%"}]}, {"boundingBox": [339, 1235, 630, 1234, 631, 1263, 340, 1264], "text": "Metformin and 8% Insulin)", "words": [{"boundingBox": [340, 1235, 454, 1236, 455, 1264, 340, 1264], "text": "Metformin"}, {"boundingBox": [460, 1236, 501, 1236, 502, 1264, 461, 1264], "text": "and"}, {"boundingBox": [507, 1236, 542, 1236, 543, 1264, 507, 1264], "text": "8%"}, {"boundingBox": [548, 1236, 629, 1235, 630, 1263, 548, 1263], "text": "Insulin)"}]}, {"boundingBox": [338, 1272, 1269, 1273, 1268, 1304, 338, 1304], "text": "Regarding the possibility of the risk of labeling revision, International Division entrusts", "words": [{"boundingBox": [341, 1273, 451, 1273, 450, 1304, 340, 1305], "text": "Regarding"}, {"boundingBox": [458, 1273, 491, 1273, 490, 1304, 457, 1304], "text": "the"}, {"boundingBox": [497, 1273, 607, 1273, 607, 1303, 496, 1304], "text": "possibility"}, {"boundingBox": [614, 1273, 637, 1273, 636, 1303, 613, 1303], "text": "of"}, {"boundingBox": [643, 1273, 676, 1273, 675, 1303, 642, 1303], "text": "the"}, {"boundingBox": [682, 1273, 724, 1273, 723, 1303, 682, 1303], "text": "risk"}, {"boundingBox": [730, 1273, 753, 1273, 752, 1303, 730, 1303], "text": "of"}, {"boundingBox": [759, 1273, 845, 1274, 844, 1303, 759, 1303], "text": "labeling"}, {"boundingBox": [851, 1274, 945, 1274, 944, 1303, 850, 1303], "text": "revision,"}, {"boundingBox": [951, 1274, 1086, 1274, 1086, 1303, 950, 1303], "text": "International"}, {"boundingBox": [1092, 1274, 1184, 1275, 1184, 1304, 1092, 1303], "text": "Division"}, {"boundingBox": [1190, 1275, 1269, 1275, 1269, 1304, 1190, 1304], "text": "entrusts", "confidence": "Low"}]}, {"boundingBox": [336, 1309, 1277, 1310, 1276, 1343, 336, 1343], "text": "Development Division with final decision. However, just to be sure, I would like to", "words": [{"boundingBox": [341, 1310, 485, 1311, 484, 1343, 341, 1343], "text": "Development"}, {"boundingBox": [491, 1311, 587, 1312, 587, 1343, 491, 1343], "text": "Division"}, {"boundingBox": [594, 1312, 644, 1312, 643, 1343, 593, 1343], "text": "with"}, {"boundingBox": [650, 1312, 707, 1312, 706, 1343, 650, 1343], "text": "final"}, {"boundingBox": [713, 1312, 807, 1312, 807, 1343, 713, 1343], "text": "decision."}, {"boundingBox": [814, 1312, 920, 1313, 920, 1343, 813, 1343], "text": "However,"}, {"boundingBox": [927, 1313, 968, 1313, 968, 1343, 926, 1343], "text": "just"}, {"boundingBox": [975, 1313, 1001, 1313, 1001, 1343, 974, 1343], "text": "to"}, {"boundingBox": [1007, 1313, 1038, 1312, 1038, 1343, 1007, 1343], "text": "be"}, {"boundingBox": [1044, 1312, 1097, 1312, 1096, 1343, 1044, 1343], "text": "sure,"}, {"boundingBox": [1103, 1312, 1118, 1312, 1118, 1342, 1103, 1342], "text": "I"}, {"boundingBox": [1125, 1312, 1192, 1312, 1192, 1342, 1125, 1342], "text": "would"}, {"boundingBox": [1199, 1312, 1243, 1312, 1242, 1342, 1199, 1342], "text": "like"}, {"boundingBox": [1249, 1312, 1275, 1312, 1275, 1342, 1249, 1342], "text": "to"}]}, {"boundingBox": [337, 1352, 985, 1355, 984, 1384, 336, 1381], "text": "reconfirm that this sNDA dose not lead to a serious situation.", "words": [{"boundingBox": [341, 1353, 441, 1353, 441, 1382, 341, 1380], "text": "reconfirm"}, {"boundingBox": [450, 1353, 492, 1353, 492, 1382, 450, 1382], "text": "that"}, {"boundingBox": [497, 1353, 535, 1354, 535, 1383, 497, 1382], "text": "this"}, {"boundingBox": [540, 1354, 608, 1354, 608, 1383, 540, 1383], "text": "sNDA"}, {"boundingBox": [617, 1354, 662, 1354, 662, 1383, 617, 1383], "text": "dose"}, {"boundingBox": [668, 1354, 702, 1355, 702, 1384, 668, 1383], "text": "not"}, {"boundingBox": [707, 1355, 752, 1355, 752, 1384, 707, 1384], "text": "lead"}, {"boundingBox": [758, 1355, 781, 1355, 781, 1384, 758, 1384], "text": "to"}, {"boundingBox": [786, 1355, 799, 1355, 799, 1384, 786, 1384], "text": "a"}, {"boundingBox": [804, 1355, 880, 1356, 880, 1383, 804, 1384], "text": "serious"}, {"boundingBox": [885, 1356, 984, 1357, 984, 1383, 885, 1383], "text": "situation."}]}, {"boundingBox": [339, 1390, 1275, 1390, 1275, 1420, 340, 1421], "text": "I heard that TPNA R&D suggested to HQ and is getting ready for sNDA for the 45mg", "words": [{"boundingBox": [340, 1391, 349, 1391, 350, 1420, 340, 1420], "text": "I"}, {"boundingBox": [355, 1391, 417, 1391, 418, 1420, 356, 1420], "text": "heard"}, {"boundingBox": [423, 1391, 469, 1392, 469, 1420, 424, 1420], "text": "that"}, {"boundingBox": [474, 1392, 541, 1392, 541, 1421, 475, 1420], "text": "TPNA"}, {"boundingBox": [546, 1392, 603, 1393, 603, 1421, 547, 1421], "text": "R&D"}, {"boundingBox": [613, 1393, 719, 1393, 719, 1421, 613, 1421], "text": "suggested"}, {"boundingBox": [724, 1393, 747, 1393, 747, 1422, 724, 1421], "text": "to"}, {"boundingBox": [753, 1393, 793, 1393, 792, 1422, 753, 1422], "text": "HQ"}, {"boundingBox": [800, 1393, 838, 1393, 838, 1422, 800, 1422], "text": "and"}, {"boundingBox": [844, 1393, 866, 1393, 866, 1422, 844, 1422], "text": "is"}, {"boundingBox": [872, 1393, 946, 1392, 946, 1422, 872, 1422], "text": "getting"}, {"boundingBox": [952, 1392, 1014, 1392, 1014, 1422, 951, 1422], "text": "ready"}, {"boundingBox": [1020, 1392, 1054, 1392, 1054, 1422, 1019, 1422], "text": "for"}, {"boundingBox": [1060, 1392, 1126, 1391, 1125, 1421, 1059, 1422], "text": "sNDA"}, {"boundingBox": [1132, 1391, 1166, 1391, 1165, 1421, 1131, 1421], "text": "for"}, {"boundingBox": [1172, 1391, 1208, 1391, 1207, 1421, 1171, 1421], "text": "the"}, {"boundingBox": [1213, 1391, 1274, 1390, 1273, 1421, 1212, 1421], "text": "45mg"}]}, {"boundingBox": [339, 1432, 1275, 1429, 1276, 1461, 340, 1464], "text": "combination indications. However, HQ should carefully judge whether this sNDA", "words": [{"boundingBox": [342, 1435, 475, 1434, 475, 1463, 342, 1462], "text": "combination"}, {"boundingBox": [486, 1434, 617, 1434, 617, 1463, 486, 1463], "text": "indications."}, {"boundingBox": [622, 1434, 732, 1433, 733, 1463, 623, 1463], "text": "However,"}, {"boundingBox": [738, 1433, 775, 1433, 776, 1463, 738, 1463], "text": "HQ"}, {"boundingBox": [790, 1433, 867, 1432, 868, 1463, 790, 1463], "text": "should"}, {"boundingBox": [874, 1432, 973, 1432, 974, 1463, 875, 1463], "text": "carefully"}, {"boundingBox": [979, 1432, 1047, 1431, 1048, 1463, 979, 1463], "text": "judge"}, {"boundingBox": [1056, 1431, 1146, 1431, 1147, 1462, 1057, 1463], "text": "whether"}, {"boundingBox": [1152, 1431, 1198, 1431, 1199, 1462, 1152, 1462], "text": "this"}, {"boundingBox": [1206, 1430, 1272, 1430, 1273, 1461, 1206, 1462], "text": "sNDA"}]}, {"boundingBox": [341, 1471, 1284, 1468, 1285, 1499, 342, 1501], "text": "should be submitted to the FDA or not. I think that sNDA for efficacy should be", "words": [{"boundingBox": [342, 1472, 417, 1473, 417, 1500, 342, 1499], "text": "should"}, {"boundingBox": [422, 1473, 454, 1473, 455, 1500, 423, 1500], "text": "be"}, {"boundingBox": [461, 1473, 570, 1473, 571, 1501, 462, 1500], "text": "submitted"}, {"boundingBox": [577, 1473, 604, 1473, 605, 1501, 578, 1501], "text": "to"}, {"boundingBox": [609, 1473, 648, 1473, 649, 1501, 610, 1501], "text": "the"}, {"boundingBox": [655, 1473, 709, 1473, 710, 1501, 656, 1501], "text": "FDA"}, {"boundingBox": [719, 1473, 746, 1473, 748, 1501, 721, 1501], "text": "or"}, {"boundingBox": [752, 1473, 800, 1472, 801, 1501, 753, 1501], "text": "not."}, {"boundingBox": [805, 1472, 821, 1472, 823, 1501, 806, 1501], "text": "I"}, {"boundingBox": [826, 1472, 885, 1472, 887, 1501, 828, 1501], "text": "think"}, {"boundingBox": [892, 1472, 940, 1472, 942, 1501, 894, 1501], "text": "that"}, {"boundingBox": [946, 1472, 1014, 1471, 1015, 1500, 947, 1501], "text": "sNDA"}, {"boundingBox": [1022, 1471, 1062, 1471, 1064, 1500, 1024, 1500], "text": "for"}, {"boundingBox": [1067, 1471, 1156, 1470, 1158, 1500, 1069, 1500], "text": "efficacy"}, {"boundingBox": [1163, 1470, 1240, 1469, 1242, 1499, 1165, 1500], "text": "should"}, {"boundingBox": [1245, 1469, 1277, 1469, 1280, 1499, 1247, 1499], "text": "be"}]}, {"boundingBox": [338, 1508, 1206, 1509, 1206, 1540, 337, 1538], "text": "submitted only when there is no risk that this sND A damages the current labeling.", "words": [{"boundingBox": [342, 1509, 446, 1509, 445, 1539, 342, 1539], "text": "submitted"}, {"boundingBox": [452, 1509, 497, 1509, 497, 1539, 451, 1539], "text": "only"}, {"boundingBox": [503, 1509, 561, 1509, 560, 1538, 503, 1539], "text": "when"}, {"boundingBox": [567, 1509, 620, 1509, 620, 1538, 566, 1538], "text": "there"}, {"boundingBox": [626, 1509, 644, 1509, 644, 1538, 626, 1538], "text": "is"}, {"boundingBox": [650, 1509, 678, 1509, 677, 1538, 650, 1538], "text": "no"}, {"boundingBox": [684, 1509, 724, 1509, 723, 1538, 683, 1538], "text": "risk"}, {"boundingBox": [730, 1509, 769, 1510, 769, 1539, 729, 1538], "text": "that"}, {"boundingBox": [775, 1510, 815, 1510, 814, 1539, 775, 1539], "text": "this"}, {"boundingBox": [821, 1510, 867, 1510, 866, 1539, 820, 1539], "text": "sND"}, {"boundingBox": [873, 1510, 890, 1510, 890, 1539, 872, 1539], "text": "A"}, {"boundingBox": [896, 1510, 986, 1510, 985, 1539, 896, 1539], "text": "damages"}, {"boundingBox": [992, 1510, 1023, 1510, 1023, 1539, 991, 1539], "text": "the"}, {"boundingBox": [1029, 1510, 1105, 1510, 1104, 1540, 1029, 1539], "text": "current"}, {"boundingBox": [1111, 1510, 1206, 1510, 1206, 1540, 1110, 1540], "text": "labeling."}]}, {"boundingBox": [349, 1549, 1278, 1549, 1277, 1578, 348, 1578], "text": "According to the results of PNFP-343, combination with insulin, edema was observed", "words": [{"boundingBox": [349, 1549, 455, 1550, 455, 1579, 349, 1579], "text": "According"}, {"boundingBox": [460, 1550, 484, 1550, 484, 1579, 461, 1579], "text": "to"}, {"boundingBox": [489, 1550, 524, 1550, 524, 1579, 490, 1579], "text": "the"}, {"boundingBox": [530, 1550, 603, 1550, 603, 1579, 530, 1579], "text": "results"}, {"boundingBox": [609, 1550, 634, 1550, 634, 1579, 609, 1579], "text": "of"}, {"boundingBox": [640, 1550, 762, 1551, 762, 1579, 640, 1579], "text": "PNFP-343,"}, {"boundingBox": [767, 1551, 902, 1551, 902, 1579, 767, 1579], "text": "combination"}, {"boundingBox": [908, 1551, 956, 1551, 956, 1579, 908, 1579], "text": "with"}, {"boundingBox": [962, 1551, 1045, 1551, 1045, 1579, 962, 1579], "text": "insulin,"}, {"boundingBox": [1051, 1551, 1122, 1550, 1122, 1579, 1051, 1579], "text": "edema"}, {"boundingBox": [1128, 1550, 1173, 1550, 1173, 1579, 1128, 1579], "text": "was"}, {"boundingBox": [1178, 1550, 1279, 1550, 1279, 1579, 1178, 1579], "text": "observed"}]}, {"boundingBox": [336, 1588, 1279, 1589, 1278, 1618, 335, 1617], "text": "more often than Avandia, which dose not have the indication for combination with", "words": [{"boundingBox": [340, 1589, 400, 1590, 401, 1618, 340, 1617], "text": "more"}, {"boundingBox": [405, 1590, 466, 1590, 466, 1618, 406, 1618], "text": "often"}, {"boundingBox": [471, 1590, 522, 1590, 523, 1618, 472, 1618], "text": "than"}, {"boundingBox": [531, 1590, 630, 1591, 630, 1619, 532, 1618], "text": "Avandia,"}, {"boundingBox": [635, 1591, 702, 1591, 703, 1619, 636, 1619], "text": "which"}, {"boundingBox": [715, 1591, 764, 1591, 765, 1619, 716, 1619], "text": "dose"}, {"boundingBox": [770, 1591, 810, 1591, 811, 1619, 771, 1619], "text": "not"}, {"boundingBox": [815, 1591, 872, 1591, 873, 1619, 816, 1619], "text": "have"}, {"boundingBox": [877, 1591, 915, 1591, 916, 1619, 878, 1619], "text": "the"}, {"boundingBox": [921, 1591, 1032, 1590, 1033, 1619, 922, 1619], "text": "indication"}, {"boundingBox": [1039, 1590, 1078, 1590, 1078, 1619, 1040, 1619], "text": "for"}, {"boundingBox": [1083, 1590, 1218, 1589, 1219, 1618, 1084, 1619], "text": "combination"}, {"boundingBox": [1225, 1589, 1276, 1589, 1277, 1618, 1226, 1618], "text": "with"}]}, {"boundingBox": [334, 1625, 924, 1627, 923, 1659, 333, 1656], "text": "insulin and CHF in this study seems to be dose related.", "words": [{"boundingBox": [341, 1625, 412, 1627, 412, 1657, 340, 1657], "text": "insulin"}, {"boundingBox": [419, 1627, 459, 1628, 458, 1657, 418, 1657], "text": "and"}, {"boundingBox": [465, 1628, 514, 1629, 513, 1657, 464, 1657], "text": "CHF"}, {"boundingBox": [520, 1629, 541, 1629, 541, 1657, 519, 1657], "text": "in"}, {"boundingBox": [547, 1629, 585, 1630, 585, 1657, 547, 1657], "text": "this"}, {"boundingBox": [592, 1630, 651, 1630, 650, 1657, 591, 1657], "text": "study"}, {"boundingBox": [657, 1630, 720, 1630, 720, 1657, 657, 1657], "text": "seems"}, {"boundingBox": [727, 1630, 748, 1631, 748, 1657, 726, 1657], "text": "to"}, {"boundingBox": [754, 1631, 783, 1630, 783, 1658, 754, 1657], "text": "be"}, {"boundingBox": [790, 1630, 832, 1630, 832, 1658, 790, 1658], "text": "dose"}, {"boundingBox": [838, 1630, 923, 1629, 923, 1658, 838, 1658], "text": "related."}]}, {"boundingBox": [141, 1937, 557, 1936, 558, 1967, 141, 1967], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [141, 1937, 258, 1940, 258, 1966, 142, 1968], "text": "Confidential"}, {"boundingBox": [264, 1940, 278, 1940, 279, 1966, 265, 1966], "text": "-"}, {"boundingBox": [284, 1940, 356, 1940, 357, 1966, 285, 1966], "text": "Subject"}, {"boundingBox": [362, 1940, 380, 1940, 381, 1966, 363, 1966], "text": "to"}, {"boundingBox": [386, 1940, 488, 1939, 489, 1966, 387, 1966], "text": "Protective"}, {"boundingBox": [494, 1939, 556, 1937, 557, 1967, 495, 1966], "text": "Order"}]}, {"boundingBox": [1223, 1936, 1472, 1936, 1471, 1963, 1222, 1962], "text": "TAK-THOMCL-00005583", "words": [{"boundingBox": [1225, 1936, 1471, 1938, 1471, 1963, 1225, 1963], "text": "TAK-THOMCL-00005583"}]}, {"boundingBox": [1223, 1969, 1541, 1970, 1541, 1995, 1222, 1994], "text": "Produced in MDL on 09/14/12", "words": [{"boundingBox": [1224, 1970, 1324, 1971, 1324, 1993, 1223, 1994], "text": "Produced"}, {"boundingBox": [1329, 1971, 1350, 1971, 1350, 1993, 1329, 1993], "text": "in"}, {"boundingBox": [1355, 1971, 1407, 1971, 1407, 1993, 1355, 1993], "text": "MDL"}, {"boundingBox": [1412, 1971, 1439, 1971, 1440, 1994, 1412, 1993], "text": "on"}, {"boundingBox": [1444, 1971, 1540, 1970, 1540, 1996, 1444, 1994], "text": "09/14/12"}]}, {"boundingBox": [383, 2193, 1317, 2193, 1317, 2230, 384, 2231], "text": "Source: https://www.indupt2290-coots.ucsf.edu/docs/syjf0226", "words": [{"boundingBox": [386, 2195, 499, 2195, 500, 2231, 387, 2230], "text": "Source:"}, {"boundingBox": [506, 2195, 1316, 2193, 1317, 2230, 507, 2231], "text": "https://www.indupt2290-coots.ucsf.edu/docs/syjf0226", "confidence": "Low"}]}]}]}